PolyActiva is excited to announce that our CEO, Vanessa Waddell, will be presenting at #AusBioInvest24 on 29 October in the 4:00pm – 4:55pm session. Vanessa will be presenting our latest 48-week clinical data from our Phase 1b/2a clinical trial, which demonstrates both the safety of repeat-dosing with our PA5108 Ocular Implant, and sustained reduction in intraocular pressure in this repeat-dose cohort out to 48 weeks. This data backs our goal of providing patients suffering from glaucoma a long-term sustained-release alternative solution to drop therapy. Thank you AusBiotech for this opportunity, we can’t wait to share these results with you and what we have on the horizon. #AusBio #AusBioInv24 #Glaucoma #Innovation
PolyActiva’s Post
More Relevant Posts
-
1️⃣ Medline Industries, LP agrees to acquire Ecolab’s surgical solutions business for $950 million, with the transaction expected to be completed in the second half of 2024. 2️⃣ Optomed Plc launches the Aurora AEYE, an AI fundus camera for instant diabetic retinopathy detection, designed for primary care settings. 3️⃣ Thermo Fisher Scientific has launched the CXCL10 test for kidney transplant patients, targeting elevated urinary CXCL10 levels associated with inflammation and early kidney transplant rejection. 4️⃣ NovaScan has selected Epredia to distribute its MarginScan device in the US, aiming to improve surgical outcomes by minimizing the removal of healthy tissue during excisions. 5️⃣ SonoVascular, Inc. has partnered with Lantheus for venous thromboembolism (VTE) treatment, where Lantheus will supply microbubbles and activation devices, while SonoVascular handles clinical studies. #InsightswithSmarteeva #Medtech #complaintmanagement #Pharma #Smarteeva #biotech #medtechtrends #medtechindustry #medicaltechnology #technology #health #medicaldevicediagnostics #ai #mdr #recalls #complaints #mir #fda #cvr
-
Driving First-to-Market Success and Sustainable Growth through High-Speed, Outcome-Focused, Science & Engineering Services for Innovators and Disruptors.
🔌 Innovating at the Intersection of Medicine and Technology ⚙️ In the ever-evolving field of medical devices, the integration of electrical systems is unlocking new possibilities for patient care. This Tech Talk between Holly Scott of the Mullings Group and David N Constantine of Juniper Biomedical, is a great reminder of how far the industry has come in improving patient outcomes, and the potential that still lies ahead. In the spirit of Copetition (Thanks Holly Scott) we help companies bring their innovative medical devices to life by combining advanced COMSOL modeling with rapid prototyping and rigorous testing. Whether it’s refining a concept or navigating the complexities of electrical design, we’re here to support every step of your device technology development journey. If you’re working on the next breakthrough in medical technology, let’s connect and explore how we can collaborate. #MedicalDevices #Neuromodulation #Electroceuticals #Bioelectronics #TechnologyDevelopment #COMSOL
Senior Partner at The Mullings Group | Global Medical Device & Life Sciences | Executive Search-Building Companies and Careers
#Neuromodulation opportunities are one of the largest areas of expected market growth trends in the next 3-5 years. The market seems to agree based on the incredible investment happening in #pelvichealth year to date. Boston Scientific acquires Axonics, Inc. for $3.4 Bil Amber Therapeutics raises $100 Mil Neuspera Medical Inc. announced $23 Mil raise Avation Medical raises $22 Mil All of this is why my discussion with David N Constantine, Co-Founder and CEO of Juniper Biomedical, couldn't have happened at a better time. David and the team are bullishly focusing on revolutionizing pelvic health therapies through precision neuromodulation. Check out our full discussion on Tech Talks in link below.
-
Allegro Biotech’s innovative injectable microparticle gel, #hydrocelin, has demonstrated favorable safety in two preclinical studies, paving the way for a breakthrough in #osteoarthritis treatment. By acting as tiny shock absorbers, hydrocelin offers immediate pain relief, helps restore mobility, and protects cartilage. “Effective disease-modifying treatments for osteoarthritis are urgently needed as our population ages, as well as for athletes who are looking for alternatives to invasive surgical procedures”, said Lucas D., CEO of Allegro. “We believe hydrocelin possesses the necessary attributes to offer osteoarthritis patients pain relief and potentially protect joints and restore mobility.” https://lnkd.in/e-AJSRdM
-
-
👏 The new financing allows Kardium Inc. to complete the PULSAR clinical study of its Globe Pulsed Field Ablation system and use the results to obtain regulatory approvals. 🗣 Kevin Chaplin, CEO of Kardium, commented: “[The investors'] enthusiasm and support reflect the incredible success we have achieved with the Globe system and the tremendous potential we have to dramatically improve the treatment of atrial fibrillation for millions of patients worldwide.” 🔗 Read more: https://lnkd.in/day6yhVk 📰 Follow Guided Solutions to receive the latest #MedTech news daily and subscribe to our weekly newsletter: https://lnkd.in/dh3kMf-a #MedicalDevices #MedicalDevice #MedicalEquipment #Medicine #HealthTech #Surgeons #GuidedSolutions
-
Companion diagnostics (CDx) can improve clinical outcomes and reduce costs associated with clinical trial research and development. Learn about important CDx considerations and how Labcorp can help advance your global CDx program: #CDx #CompanionDiagnostics #PrecisionMedicine
Advancing your global companion diagnostics program: Insights from a recent Japan symposium (Part 1)
learn-more.com
-
Vice President and Enterprise Head of Cell and Gene Therapy at Labcorp Drug Development
Companion diagnostics (CDx) can improve clinical outcomes and reduce costs associated with clinical trial research and development. Learn about important CDx considerations and how Labcorp can help advance your global CDx program: #CDx #CompanionDiagnostics #PrecisionMedicine
Advancing your global companion diagnostics program: Insights from a recent Japan symposium (Part 1)
learn-more.com
-
🌟 Talent Acquisition Manager at Labcorp | Passionate about Connecting Talent with Opportunity and Leading the Future Recruiters| Champion for Military, Military Spouses, and Veterans 🌟
Companion diagnostics (CDx) can improve clinical outcomes and reduce costs associated with clinical trial research and development. Learn about important CDx considerations and how Labcorp can help advance your global CDx program: #CDx #CompanionDiagnostics #PrecisionMedicine
Advancing your global companion diagnostics program: Insights from a recent Japan symposium (Part 1)
learn-more.com
-
Companion diagnostics (CDx) can improve clinical outcomes and reduce costs associated with clinical trial research and development. Learn about important CDx considerations and how Labcorp can help advance your global CDx program: #CDx #CompanionDiagnostics #PrecisionMedicine
Advancing your global companion diagnostics program: Insights from a recent Japan symposium (Part 1)
learn-more.com
-
Companion diagnostics (CDx) can improve clinical outcomes and reduce costs associated with clinical trial research and development. Learn about important CDx considerations and how Labcorp can help advance your global CDx program: #CDx #CompanionDiagnostics #PrecisionMedicine
Advancing your global companion diagnostics program: Insights from a recent Japan symposium (Part 1)
learn-more.com
-
Companion diagnostics (CDx) can improve clinical outcomes and reduce costs associated with clinical trial research and development. Learn about important CDx considerations and how Labcorp can help advance your global CDx program: #CDx #CompanionDiagnostics #PrecisionMedicine
Advancing your global companion diagnostics program: Insights from a recent Japan symposium (Part 1)
learn-more.com
